Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2011-02-28

FDA Approved: METOCLOPRAMIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

The FDA approved Teva's supplemental application for metoclopramide, resulting in changes to the drug's labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Metoclopramide (metoclopramide)

Snippet

SUPPL AP for METOCLOPRAMIDE (METOCLOPRAMIDE)